Starling Oncology, Inc. Treasury Stock, Common, Value
Starling Oncology, Inc. (DFPH) had Treasury Stock, Common, Value of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-08-06
- 2026-06-30: Treasury Stock, Common, Value $1.02M.
- 2026-03-31: Treasury Stock, Common, Value $1.02M.
- 2025-12-31: Treasury Stock, Common, Value $1.02M.
- 2025-09-30: Treasury Stock, Common, Value $1.02M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.02M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.02M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.02M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.02M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.02M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.02M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.02M 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $894.00K 10-Q · filed 2023-08-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |